Katayoun Rezvani

28.0k total citations · 4 hit papers
216 papers, 11.2k citations indexed

About

Katayoun Rezvani is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, Katayoun Rezvani has authored 216 papers receiving a total of 11.2k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Immunology, 111 papers in Hematology and 97 papers in Oncology. Recurrent topics in Katayoun Rezvani's work include Immune Cell Function and Interaction (82 papers), CAR-T cell therapy research (75 papers) and Hematopoietic Stem Cell Transplantation (69 papers). Katayoun Rezvani is often cited by papers focused on Immune Cell Function and Interaction (82 papers), CAR-T cell therapy research (75 papers) and Hematopoietic Stem Cell Transplantation (69 papers). Katayoun Rezvani collaborates with scholars based in United States, United Kingdom and Germany. Katayoun Rezvani's co-authors include Elizabeth J. Shpall, May Daher, Rohtesh S. Mehta, Alexander Biederstädt, A. John Barrett, Rayne H. Rouce, Tamara Laskowski, Mayela Carolina Mendt, Stephan Mielke and Bipin N. Savani and has published in prestigious journals such as New England Journal of Medicine, Cell and Nature Communications.

In The Last Decade

Katayoun Rezvani

206 papers receiving 11.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chimeric antigen receptor T-cell therapy — assessment and management of toxicities

2017 1.6k citations Partow Kebriaei, Alison Gulbis et al. profile →
Generation and testing of clinical-grade exosomes for pancreatic cancer

2018 633 citations Mayela Carolina Mendt, Katayoun Rezvani et al. profile →
Natural killer cells in antitumour adoptive cell immunotherapy

2022 469 citations Katayoun Rezvani et al. profile →
Mesenchymal stem cell-derived exosomes for clinical use

2019 368 citations Mayela Carolina Mendt, Katayoun Rezvani et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katayoun Rezvani United States	51	5.5k	4.9k	3.6k	2.8k	1.7k	216	11.2k
Angela Panoskaltsis‐Mortari United States	69	4.7k 0.9×	10.5k 2.2×	5.2k 1.4×	2.2k 0.8×	1.2k 0.7×	275	16.2k
Richard Childs United States	57	3.8k 0.7×	4.6k 0.9×	4.6k 1.3×	2.3k 0.8×	1.5k 0.9×	273	10.7k
Robert S. Negrin United States	71	6.0k 1.1×	10.2k 2.1×	6.9k 1.9×	3.3k 1.2×	1.9k 1.1×	307	18.0k
Robert Zeiser Germany	56	2.8k 0.5×	5.2k 1.1×	4.5k 1.3×	2.8k 1.0×	1.2k 0.7×	287	11.4k
Maurilio Ponzoni Italy	65	6.6k 1.2×	3.8k 0.8×	1.7k 0.5×	4.7k 1.7×	3.2k 1.9×	296	16.6k
Crystal L. Mackall United States	61	7.1k 1.3×	8.5k 1.7×	2.3k 0.6×	3.2k 1.1×	660 0.4×	168	16.1k
Russell S. Taichman United States	59	7.6k 1.4×	3.7k 0.8×	2.9k 0.8×	5.0k 1.8×	2.2k 1.3×	186	14.8k
Daniel C. Link United States	62	3.1k 0.6×	5.4k 1.1×	4.9k 1.4×	4.2k 1.5×	2.5k 1.5×	209	13.3k
Sattva S. Neelapu United States	50	8.8k 1.6×	4.3k 0.9×	1.1k 0.3×	3.3k 1.2×	1.5k 0.9×	418	13.4k
Rupert Handgretinger Germany	70	5.4k 1.0×	7.0k 1.4×	6.4k 1.8×	5.3k 1.9×	2.2k 1.3×	493	19.0k

Countries citing papers authored by Katayoun Rezvani

Since Specialization

Citations

This map shows the geographic impact of Katayoun Rezvani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katayoun Rezvani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katayoun Rezvani more than expected).

Fields of papers citing papers by Katayoun Rezvani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katayoun Rezvani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katayoun Rezvani. The network helps show where Katayoun Rezvani may publish in the future.

Co-authorship network of co-authors of Katayoun Rezvani

This figure shows the co-authorship network connecting the top 25 collaborators of Katayoun Rezvani. A scholar is included among the top collaborators of Katayoun Rezvani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katayoun Rezvani. Katayoun Rezvani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mehta, Rohtesh S., Yosra Aljawai, Partow Kebriaei, et al.. (2025). The Impact of Isolated HLA-DQB1 Mismatch and Donor Age in Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide. Transplantation and Cellular Therapy. 31(11). 920.e1–920.e14. 1 indexed citations

Aljawai, Yosra, Jeremy Ramdial, Gabriela Rondón, et al.. (2025). Outcomes of haploidentical vs mismatched unrelated donor HCT with posttransplant cyclophosphamide prophylaxis. Blood Advances. 9(15). 4023–4036. 2 indexed citations

Mulla, Abeda, David Allan, Brynn B. Duncan, et al.. (2025). Optimization of lentiviral delivery of barcoded anti-CD20 chimeric antigen receptors into rhesus macaque and human natural killer cells. Molecular Therapy — Methods & Clinical Development. 33(2). 101473–101473.

Ramdial, Jeremy, Laura Di Clemente, Pinaki P. Banerjee, et al.. (2024). Phase II Clinical Trial of “Off-the-Shelf” NK Cells with Allogeneic Stem Cell Transplantation in Patients with High-Risk Myeloid Malignancies. Blood. 144(Supplement 1). 4841–4841.

Rafei, Hind & Katayoun Rezvani. (2024). Mitigating infection risks: The promise and challenge of bispecific antibodies in haematological malignancies. British Journal of Haematology. 205(3). 764–766. 4 indexed citations

Saliba, Rima M., Christopher G. Kanakry, Shahinaz M. Gadalla, et al.. (2023). Effect of donor age in patients with acute myeloid leukemia undergoing haploidentical hematopoietic cell transplantation vary by conditioning intensity and recipient age. American Journal of Hematology. 99(1). 38–47. 7 indexed citations

Mehta, Rohtesh S., Jeremy Ramdial, David Marín, et al.. (2023). Impact of Donor Age in Haploidentical-Post-Transplantation Cyclophosphamide versus Matched Unrelated Donor Post-Transplantation Cyclophosphamide Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia. Transplantation and Cellular Therapy. 29(6). 377.e1–377.e7. 14 indexed citations

Li, Ye, Katayoun Rezvani, & Hind Rafei. (2023). Next‐generation chimeric antigen receptors for T‐ and natural killer‐cell therapies against cancer. Immunological Reviews. 320(1). 217–235. 18 indexed citations

Mehta, Rohtesh S., Amin M. Alousi, Christopher G. Kanakry, et al.. (2023). Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor type. Blood Advances. 7(8). 1594–1603. 13 indexed citations

10.

Harrington, Patrick, Claire Harrison, Richard Dillon, et al.. (2021). Evidence of robust memory T‐cell responses in patients with chronic myeloproliferative neoplasms following infection with severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2). British Journal of Haematology. 193(4). 692–696. 5 indexed citations

11.

Ciurea, Stefan O., Piyanuch Kongtim, Doris Soebbing, et al.. (2021). Decrease post-transplant relapse using donor-derived expanded NK-cells. Leukemia. 36(1). 155–164. 65 indexed citations

12.

Saliba, Rima M., Uri Greenbaum, Qing Ma, et al.. (2021). Mismatch in SIRPα, a regulatory protein in innate immunity, is associated with chronic GVHD in hematopoietic stem cell transplantation. Blood Advances. 5(17). 3407–3417. 5 indexed citations

13.

Rezvani, Katayoun, Betül Oran, Rohtesh S. Mehta, et al.. (2018). Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid Leukemia. Biology of Blood and Marrow Transplantation. 25(3). 505–514. 14 indexed citations

14.

Ciurea, Stefan O., Jolie Schafer, Roland L. Bassett, et al.. (2017). Phase 1 clinical trial using mbIL21 ex vivo–expanded donor-derived NK cells after haploidentical transplantation. Blood. 130(16). 1857–1868. 250 indexed citations

15.

Daher, May, Rafet Başar, Hila Shaim, et al.. (2017). The TGF-β/SMAD Signaling Pathway As a Mediator of NK Cell Dysfunction and Immune Evasion in Myelodysplastic Syndrome. Blood. 130. 53–53. 17 indexed citations

16.

Ciurea, Stefan O., Doris Soebbing, Gabriela Rondón, et al.. (2017). Interim Results of a Phase 2 Clinical Trial Using Mb-IL21 Ex Vivo Expanded NK Cells to Enhance Graft Versus Leukemia Effect for Patients with Myeloid Malignancies after Haploidentical Transplantation. Blood. 130. 3179–3179. 2 indexed citations

17.

Vitale, Candida, Lorenzo Falchi, Elisa ten Hacken, et al.. (2016). Ofatumumab and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Correlation between Responses and Immune Characteristics. Clinical Cancer Research. 22(10). 2359–2367. 23 indexed citations

18.

Grube, Matthias, Ellen C. Obermann, Katayoun Rezvani, et al.. (2007). CD8+ T cells Reactive to Survivin Antigen in Patients with Multiple Myeloma. Clinical Cancer Research. 13(3). 1053–1060. 27 indexed citations

19.

Barrett, John & Katayoun Rezvani. (2005). Neutrophil granule proteins as targets of leukemia-specific immune responses. Current Opinion in Hematology. 13(1). 15–20. 8 indexed citations

20.

Sconocchia, Giuseppe, Keyvan Keyvanfar, Frank El Ouriaghli, et al.. (2004). Phenotype and function of a CD56+ peripheral blood monocyte. Leukemia. 19(1). 69–76. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact